• 2:30 PM - 3:00 PM Registration
• 3:00 PM - 4:00 PM Seminar
• 4:00 PM - 4:30 PM Q&A;
Ving Lee, PhD - Senior Vice President, Research, Limerick BioPharma - has devoted many years to the discovery of new anti-infectives. He will discuss how revisiting old natural products, with defined endpoints for clinical needs, provides potential commercial opportunities; examples from the discovery of new tetracyclines, beta-lactams for problematic Gram-positive pathogens, and uridyl peptide antibiotics will be highlighted. He will also discuss how observations from the above work led to a component of the technology platform of Limerick Biopharm Inc.
Ving Lee, PhD, Senior Vice President, Research, Limerick BioPharma
Ving Lee has broad expertise gained from both research and executive positions in the pharmaceutical industry as well as academic appointments. After post-doctoral appointments at the University of Illinois and Harvard (NIH), he held leadership positions at Lederle Laboratories (Cyanamid), Microcide Pharmaceuticals, Iconix Pharmaceuticals (Iconix Biosciences) and Anacor Pharmaceuticals.
From 2002 to 2004, Dr. Lee was Chief Scientific Officer and Vice President, Discovery Research at Anacor Pharmaceuticals, Inc. where he directed research on boron-based therapeutics with support from a $22.6 million Defense Advance Research Projects Agency contract. Previously, Dr. Lee held various positions at i) Microcide Pharmaceuticals including Vice President, Chemistry and Pre-clinical Research; Research Operations and Technology Assessment; and Senior Research Advisor and ii) Lederle-American Cyanamid responsible for research in beta-lactams for problematic gram-positive pathogens, broad-spectrum beta-lactams, tetracyclines, gyrase inhibitors, uridyl-peptide antibiotics, inhibitors of bacterial efflux pumps, and natural product-based anti-infectives.
Dr. Lee received his BA and MS-PhD from Ohio State University and the University of Illinois at Urbana-Champaign, respectively. Concurrent to his position as Senior Vice President, Research at Limerick NeuroSciences, Dr. Lee is also Chief Executive Officer and Chief Scientific Officer of Adesis, Inc., a contract research organization for chemistry research. He is also either a consultant or scientific advisory board member for several biotech companies.
Cost & Registration
• Regular Price: $30
• Partners' Network: $20
• BioCenter Members: Free
• On-site Registration, if space allows: add $10 to the above
The San Jose BioCenter
5941 Optical Court
San Jose, CA 95138
Click here for Venue Directions»